Statin Choice Decision Aid Implementation First Phase
- Conditions
- Cardiovascular Factor Risk
- Interventions
- Other: Statin Choice Implementation
- Registration Number
- NCT02375815
- Lead Sponsor
- Mayo Clinic
- Brief Summary
This study is designed to answer a key question in the field of implementation science. Specifically, it seeks to determine if a proposed model for the implementation and scale-up of healthcare innovations (the AIDED model) is effective and useful. To fully evaluate the potential of this model, the investigators will conduct a multi-year study comprising 3 phases. This proposal represents the first of these phases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 313
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Statin Choice Implementation Statin Choice Implementation -
- Primary Outcome Measures
Name Time Method Effective Implementation of Statin Choice Decision Aid (SCDA), as indicated by the cumulative reach (% usage in appropriate primary care consultations) across all 3 health systems (as measured by EMR-based calculations). 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States
Mosaic Life Care
🇺🇸St. Joseph, Missouri, United States
Kootenai Health
🇺🇸Coeur d'Alene, Idaho, United States
Altru Health System
🇺🇸Grand Forks, North Dakota, United States